Revista espanola de enfermedades digestivas | 2019 | Wang NN, Ou SQ, Yao J, Li DF
Journal and index pages often block iframe embedding. This reader keeps the evidence details in Orthonotes and leaves the source page one click away.
[Indexed for MEDLINE] 19. J Obstet Gynaecol. 2017 Jan;37(1):5-10. doi: 10.1080/01443615.2016.1205567. Epub 2016 Oct 19. Management of gynaecologic plasmacytoma: A review article. Feldman AM(1), Zhang Z(2), Buekers T(3), Elshaikh MA(1). Author information: (1)a Department of Radiation Oncology , Henry Ford Hospital , Detroit , MI , USA. (2)b Department of Pathology , Henry Ford Hospital , Detroit , MI , USA. (3)c Division of Gynaecologic Oncology, Department of Women's Health Services , Henry Ford Hospital , Detroit , MI , USA. In contrast to multiple myeloma (MM) which exhibits diffuse bone marrow and other organ involvement, solitary plasmacytomas carry a favourable prognosis. Extramedullary plasmacytomas (EMP) are a unique form of plasma cell neoplasms. These tumours are rare in the female reproductive tract. Only 24 cases of gynaecologic plasmacytomas were reported to date (7 cases were solitary plasmacytomas and 17 cases were either part of disseminated MM with involvement of a gynaecologic organ or were lacking complete work-up to rule out MM). The standard care of gynaecologic solitary EMP is surgical resection alone when feasible. Adjuvant radiation therapy may be considered for adverse prognostic factors such as positive resection margins. MM with gynaecologic organ involvement should be managed with systemic therapy and defer local therapies to symptomatic progression. DOI: 10.1080/01443615.2016.1205567
This article has not been linked to a wiki topic yet.
This article has not been linked to a case yet.
This article has not been linked to an atlas yet.